Exemption Decisions (CBCA)

The following summarizes the Exemption Decisions made by the Director under the Canada Business Corporations Act.

BCE INC.

Decision No.:  E-027/16

It has been determined that the management of BCE INC. is exempt pursuant to subsection 151(1) of the Canada Business Corporations Act (CBCA) from the requirement of subsection 150(1) of the CBCA to send the prescribed management proxy circular to each shareholder whose proxy is solicited for the annual meeting of shareholders to be held on or about April 26, 2017.

The exemption has been granted on the basis that the corporation is a distributing corporation, as defined in the CBCA, and that the corporation makes the prescribed management proxy circular accessible as well as sends a notice thereof, in accordance with National Instrument 54-101 Communication with Beneficial Owners of Securities of a Reporting Issuer and National Instrument 51-102 Continuous Disclosure Obligations, to each shareholder whose proxy is solicited.

This exemption has been granted on December 19, 2016.

IOGEN HOLDINGS CORPORATION

Decision No.:  E-028/16

It has been determined that the management of IOGEN HOLDINGS CORPORATION is exempt pursuant to subsection 151(1) of the Canada Business Corporations Act from the requirements of section 149 and subsection 150(1) of the Act to send the prescribed form of proxy and management proxy circular, for the annual meeting of shareholders to be held on or about February 14, 2017.

This exemption has been granted on December 20, 2016.

IntelliPharmaCeutics International Inc.

Decision No.:  E-029/16

It has been determined that the management of IntelliPharmaCeutics International Inc. is exempt pursuant to subsection 151(1) of the Canada Business Corporations Act (CBCA) from the requirement of subsection 150(1) of the CBCA to send the prescribed management proxy circular to each shareholder whose proxy is solicited for the annual and special meeting of shareholders to be held on or about April 18, 2017.

The exemption has been granted on the basis that the corporation is a distributing corporation, as defined in the CBCA, and that the corporation makes the prescribed management proxy circular accessible as well as sends a notice thereof, in accordance with National Instrument 54-101 Communication with Beneficial Owners of Securities of a Reporting Issuer and National Instrument 51-102 Continuous Disclosure Obligations, to each shareholder whose proxy is solicited.

This exemption has been granted on December 20, 2016.

TITANIUM CORPORATION INC.

Decision No.:  E-030/16

It has been determined that the management of TITANIUM CORPORATION INC. is exempt pursuant to subsection 151(1) of the Canada Business Corporations Act (CBCA) from the requirement of subsection 150(1) of the CBCA to send the prescribed management proxy circular to each shareholder whose proxy is solicited for the annual and special meeting of shareholders to be held on or about February 9, 2017.

The exemption has been granted on the basis that the corporation is a distributing corporation, as defined in the CBCA, and that the corporation makes the prescribed management proxy circular accessible as well as sends a notice thereof, in accordance with National Instrument 54-101 Communication with Beneficial Owners of Securities of a Reporting Issuer and National Instrument 51-102 Continuous Disclosure Obligations, to each shareholder whose proxy is solicited.

This exemption has been granted on December 20, 2016.

BROOKFIELD RENEWABLE POWER PREFERRED EQUITY INC.
ACTIONS PRIVILIGIEES ENERGIE RENOUVELABLE BROOKFIELD INC.

Decision No.: F-003/16

It has been determined, pursuant to section 156 of the Canada Business Corporations Act, that the corporation is exempt from the publication of all the statements prescribed in section 72 of the Regulations, for the financial year ending on or about December 31, 2016.

This decision has been rendered on December 2, 2016.

CORPORATION FONDS BANQUE NATIONALE
NATIONAL BANK FUNDS CORPORATION

Decision No.:  H-006/16

It has been determined, pursuant to subsection 171(2) of the Canada Business Corporations Act, that CORPORATION FONDS BANQUE NATIONALE / NATIONAL BANK FUNDS CORPORATION is authorized to dispense with an audit committee, as required under subsection 171(1) of the Act, for the financial year ending on or about December 31, 2017.

The exemption has been granted on the basis that the corporation is complying with the financial review requirements for investment funds in accordance with National Instrument 52-110 Audit Committees and National Instrument 81-106 Investment Fund Continuous Disclosure Obligations.

This exemption has been granted on December 13, 2016.

National Bank AltaFund Investment Corp.

Decision No.:  H-007/16

It has been determined, pursuant to subsection 171(2) of the Canada Business Corporations Act, that National Bank AltaFund Investment Corp. is authorized to dispense with an audit committee, as required under subsection 171(1) of the Act, for the financial year ending on or about December 31, 2017.

The exemption has been granted on the basis that the corporation is complying with the financial review requirements for investment funds in accordance with National Instrument 52-110 Audit Committees and National Instrument 81-106 Investment Fund Continuous Disclosure Obligations.

This exemption has been granted on December 13, 2016.

National Bank Dividend Income Fund Inc.
Fonds de revenu de dividendes Banque Nationale inc.

Decision No.:  H-008/16

It has been determined, pursuant to subsection 171(2) of the Canada Business Corporations Act, that National Bank Dividend Income Fund Inc. / Fonds de revenu de dividendes Banque Nationale inc. is authorized to dispense with an audit committee, as required under subsection 171(1) of the Act, for the financial year ending on or about December 31, 2017.

The exemption has been granted on the basis that the corporation is complying with the financial review requirements for investment funds in accordance with National Instrument 52-110 Audit Committees and National Instrument 81-106 Investment Fund Continuous Disclosure Obligations.

This exemption has been granted on December 13, 2016.

Date modified: